Enzyme replacement therapy in type III Gaucher disease
J Inherit Metab Dis
.
1999 Apr;22(2):203-4.
doi: 10.1023/a:1005495229655.
Authors
A Tylki-Szymańska
1
,
B Czartoryska
Affiliation
1
Department of Metabolic Diseases, Children's Memorial Health Institute, Warsaw, Poland.
PMID:
10234625
DOI:
10.1023/a:1005495229655
No abstract available
MeSH terms
Adolescent
Child
Child, Preschool
Gaucher Disease / drug therapy*
Glucosylceramidase / therapeutic use*
Humans
Treatment Outcome
Substances
alglucerase
Glucosylceramidase